ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,101.24
-0.29%
US Tech 100
21,156.80
-0.70%
다우존스 지수
44,424.25
-0.32%
Bitcoin
100,551.04
-2.06%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Alpha Tau Medical Ltd (DRTS) 시세

Alpha Tau Medical Ltd

Alpha Tau Medical Ltd (DRTS)

NASDAQ
4.03
-0.03
(-0.74%)
마감 27 1월 6:00AM
15분 지연
4.10
0.07
(1.74%)
시간외 거래: 9:59AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
4.03
매수가
3.63
매도가
4.19
거래량
133,087
3.82 일간 변동폭 4.12
1.75 52주 범위 4.12
market_cap
280.773M
전일 종가
4.06
개장가
4.08
최근 거래 시간
2
@
3.83
마지막 거래 시간
재정 규모
US$ 536,777
VWAP
4.0333
평균 볼륨(3m)
67,425
발행 주식
69,670,612
배당수익률
-
주가수익률
-9.80
주당순이익(EPS)
-0.42
매출
-
순이익
-29.16M

Alpha Tau Medical Ltd 정보

Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.

섹터
Surgical,med Instr,apparatus
산업
Surgical,med Instr,apparatus
웹사이트
www.alphatau.com
본부
Jerusalem, Jerusalem, Isr
설립됨
-
Alpha Tau Medical Ltd is listed in the Surgical,med Instr,apparatus sector of the 나스닥 with ticker DRTS. The last closing price for Alpha Tau Medical was US$4.06. Over the last year, Alpha Tau Medical shares have traded in a share price range of US$ 1.75 to US$ 4.12.

Alpha Tau Medical currently has 69,670,612 shares in issue. The market capitalisation of Alpha Tau Medical is US$282.86 million. Alpha Tau Medical has a price to earnings ratio (PE ratio) of -9.80.

DRTS 최신 뉴스

추가 뉴스

Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day

JERUSALEM, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

18 12월 2024
GlobeNewswire Inc.

Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor

JERUSALEM, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha...

17 12월 2024
GlobeNewswire Inc.

Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference

JERUSALEM, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

11 12월 2024
GlobeNewswire Inc.

Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium

JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

06 12월 2024
GlobeNewswire Inc.

Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

- Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha DaRT® for patients with recurrent glioblastoma...

20 11월 2024
GlobeNewswire Inc.

Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference

JERUSALEM, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

13 11월 2024
GlobeNewswire Inc.

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

JERUSALEM, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-emitters cancer therapy Alpha...

21 10월 2024
GlobeNewswire Inc.

Alpha Tau Treats First Patient with Recurrent Lung Cancer

JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

10 10월 2024
GlobeNewswire Inc.

Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC

JERUSALEM, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

20 9월 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

22 8월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.133.333333333333.94.123.875900383.98537127CS
40.93303.14.123.011217123.6742101CS
121.6972.22222222222.344.122.14674253.25631479CS
261.9795.63106796122.064.121.93425482.94416422CS
521.0334.333333333334.121.75388162.80044197CS
156-7.52-65.108225108211.5520.651.75937948.68397589CS
260-7.52-65.108225108211.5520.651.75937948.68397589CS

DRTS - Frequently Asked Questions (FAQ)

What is the current Alpha Tau Medical share price?
The current share price of Alpha Tau Medical is US$ 4.03
How many Alpha Tau Medical shares are in issue?
Alpha Tau Medical has 69,670,612 shares in issue
What is the market cap of Alpha Tau Medical?
The market capitalisation of Alpha Tau Medical is USD 282.86M
What is the 1 year trading range for Alpha Tau Medical share price?
Alpha Tau Medical has traded in the range of US$ 1.75 to US$ 4.12 during the past year
What is the PE ratio of Alpha Tau Medical?
The price to earnings ratio of Alpha Tau Medical is -9.8
What is the reporting currency for Alpha Tau Medical?
Alpha Tau Medical reports financial results in USD
What is the latest annual profit for Alpha Tau Medical?
The latest annual profit of Alpha Tau Medical is USD -29.16M
What is the registered address of Alpha Tau Medical?
The registered address for Alpha Tau Medical is KIRYAT HAMADA ST. 5, JERUSALEM, JERUSALEM, 9777605
What is the Alpha Tau Medical website address?
The website address for Alpha Tau Medical is www.alphatau.com
Which industry sector does Alpha Tau Medical operate in?
Alpha Tau Medical operates in the SURGICAL,MED INSTR,APPARATUS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
US$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
US$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
US$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
US$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
US$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
US$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
US$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
ACONAclarion Inc
US$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
US$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
US$ 142.62
(-3.12%)
232.88M

DRTS Discussion

게시물 보기
PonkenPlonken PonkenPlonken 6 일 전
Its relevant for people that are new to the board. Always look at how they started.
cliffnotes. Keep in mind the company is based in Jerusalem.

- The transaction represents an implied pro forma equity value of approximately $1 billion and is expected to provide up to $367 million in gross proceeds, including up to $275 million of cash held in the trust account of Healthcare Capital Corp. (Nasdaq: HCCC) and a $92 million PIPE.

- Citigroup is acting as financial advisor to Alpha Tau. Citigroup, Piper Sandler, and Cantor Fitzgerald are acting as joint placement agents on the PIPE. Cantor Fitzgerald is acting as a capital markets advisor to HCC. Value Base M&A Ltd. is also acting as financial advisor on the transaction.

Latham & Watkins LLP and Meitar | Law Offices are acting as legal advisors to Alpha Tau. Ellenoff Grossman & Schole LLP and FBC & Co. are acting as legal advisors to HCC. Winston & Strawn LLP is acting as legal advisor to the placement agents.
👍️0
theswordman theswordman 6 일 전
You posted the same link 1 month ago.

Also that article/link is 3 1/2 years old
👍️0
PonkenPlonken PonkenPlonken 1 주 전
coming to life
https://www.alphatau.com/single-post/alpha-tau-healthcare-capital-corp-to-combine-and-create-a-1-billion-publicly-traded-company
👍️0
TrendTrade2016 TrendTrade2016 1 주 전
DRTS GOOD BIOS WITH A STRONG PIPELINE WILL DO OKAY IN 2025...SPEC BIOS WILL GET WIPED OUT!
👍️0
TrendTrade2016 TrendTrade2016 1 주 전
DRTS BREAKING 4 BUCKS ON ITS WAY TO 4.59 TARGET...WEEKLY BREAK OUT
👍️0
Acme Investments Acme Investments 2 주 전
👇 This is what happens when you show up after the stock moves!! Headed back to 2's then maybe back up!!
👍️0
Acme Investments Acme Investments 2 주 전
Now you want to be the Riddler?? Lol!! I'm busy mastering my universe!!
👍️0
Acme Investments Acme Investments 2 주 전
You can get did you put over 10K worth of confidence in it!!
👍️0
theswordman theswordman 2 주 전
Can I get part of that "no post before JAN" bet ??
👍️0
TrendTrade2016 TrendTrade2016 2 주 전
WHEN WE ARE OUT OF THIS MARKET CHOP...DO YOU KNOW WHAT THE CHOP IS.....GOOGLE IT..YA MIGHT LEARN SOMETHING.
👍️0
Acme Investments Acme Investments 2 주 전
I put it on my watch list!! 4.50 when?? This year, month, week?? I'm on to you!! Another empty prediction!!
👍️0
TrendTrade2016 TrendTrade2016 2 주 전
WEIRDO...WATCH AND LEARN T0 4.50
👍️0
Acme Investments Acme Investments 2 주 전
I bet you don't have a post before January!! My name is Acme and I approve this message!!
👍️0
TrendTrade2016 TrendTrade2016 2 주 전
DRTS...ADDING DIPS...FAVO BIO FOR 2025
👍️0
theswordman theswordman 2 주 전
👍️0
PonkenPlonken PonkenPlonken 3 주 전
here it comes
👍️0
TrendTrade2016 TrendTrade2016 3 주 전
DRTS HERE WE GO
👍️0
TrendTrade2016 TrendTrade2016 3 주 전
DRTS NEW BIO BEAST AS WEEKLY SETS UP FOR BREAK OUT
👍️0
theswordman theswordman 3 주 전
Investor update day


👍️0
PonkenPlonken PonkenPlonken 1 월 전
https://www.ourcrowd.com/startup-news/alpha-tau-100-complete-response-rate-in-skin-cancer-trial?
might become SOC in inoperable tumors - super tech - revolutionize radio
👍️0
PonkenPlonken PonkenPlonken 1 월 전
has a lot of critical readouts coming soon - see below
neglected and forgotten...
👍️0
PonkenPlonken PonkenPlonken 1 월 전
https://www.alphatau.com/single-post/alpha-tau-healthcare-capital-corp-to-combine-and-create-a-1-billion-publicly-traded-company
👍️0
PonkenPlonken PonkenPlonken 2 월 전
Great Israeli company -- coming to life ahead of a few readouts
👍️0
theswordman theswordman 2 월 전
3rd QTR update: 2+ years op cash. Trial expansion.
FDA accepted for TAP--Total Product Life Cycle Advisory Program (TAP)
FDA approval of an Investigational Device Exemption (IDE) application for cSCC

https://www.alphatau.com/single-post/alpha-tau-medical-announces-third-quarter-2024-financial-results-and-provides-corporate-update
👍️0
theswordman theswordman 3 월 전
AlphaTau into the FDAs TPLC program: https://www.alphatau.com/single-post/alpha-tau-announces-acceptance-into-fda-s-total-product-life-cycle-advisory-program-to-accelerate-ma

Here is link that explains what that program helps with : https://www.fda.gov/medical-devices/how-study-and-market-your-device/total-product-life-cycle-advisory-program-tap
👍️0
theswordman theswordman 4 월 전
1st lung cancer patient treated--https://www.alphatau.com/single-post/alpha-tau-treats-first-patient-with-recurrent-lung-cancer

“The treatment makes use of bronchoscopic endobronchial ultrasound to insert the Alpha DaRT sources.

examining its application to an organ such the lung, given its proximity to vital healthy organs, may hopefully open new doors to a global population of patients with otherwise poor treatment options
👍️0
theswordman theswordman 4 월 전
Emory Univ wants another trial for subpopulation

https://www.alphatau.com/single-post/fda-approval-of-ide-to-initiate-multi-center-investigator-initiated-study-of-alpha-dart-in-immunoco
👍️0
theswordman theswordman 4 월 전
The big boys are correct. Just a little off ontheir delivery and MOA

https://www.cnbc.com/2024/09/16/radiopharmaceuticals-race-heats-up-as-drugmakers-chase-novartis.html
👍️0
theswordman theswordman 5 월 전
2nd qtr update

https://www.alphatau.com/single-post/alpha-tau-medical-announces-second-quarter-2024-financial-results-and-provides-corporate-update
👍️0
theswordman theswordman 7 월 전
Atlanta TV discussing AlphaDart trial at Emory Univ.

https://www.atlantanewsfirst.com/2024/06/25/emory-doctor-hopeful-about-clinical-trial-new-skin-cancer-treatment/

https://clinicaltrials.gov/study/NCT05323253?term=alpha%20tau&intr=alpha%20dart&page=2&rank=20#study-overview
👍️0
theswordman theswordman 7 월 전
Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers

https://www.alphatau.com/single-post/alpha-tau-announces-publication-in-cancers-journal-of-long-term-safety-and-efficacy-data-in-multiple
👍️0
Monksdream Monksdream 7 월 전
DRTS under $3
👍️0
theswordman theswordman 8 월 전
https://www.alphatau.com/single-post/alpha-tau-medical-announces-first-quarter-2024-financial-results-and-provides-corporate-update
👍️0
theswordman theswordman 8 월 전
https://www.alphatau.com/single-post/alpha-tau-announces-alpha-dart-treatment-of-first-patient-with-liver-metastases-of-colorectal-cancer
👍️0
theswordman theswordman 9 월 전
Bassett is one of two Alpha DaRT trial sites in New York State, the other being Memorial Sloan Kettering Cancer Center in New York City.

https://www.allotsego.com/skin-cancer-treatment-trials-open/
👍️0
theswordman theswordman 9 월 전
March Investor Deck

https://www.alphatau.com/_files/ugd/89ab89_701f2ad74a4c4684b223cb427cf79506.pdf
👍️0
theswordman theswordman 1 년 전
AlphaTau--Sidoti Conference

https://www.alphatau.com/single-post/alpha-tau-to-participate-in-sidoti-small-cap-conference

OR

https://www.meetmax.com/sched/event_98459/conference_presentations.html?bank_access=0&event_id=98459

This is from 07 DEC (THURS) @ 9:15 AM
👍️0
theswordman theswordman 1 년 전
Pancreatic Cancer Trial--early results
https://www.alphatau.com/single-post/highly-promising-interim-results-of-alpha-dart-treatment-of-advanced-pancreatic-cancer
👍️0
theswordman theswordman 1 년 전
Japan’s Pharmaceuticals and Medical Devices Agency (“PMDA”) has accepted Alpha Tau’s submission requesting shonin pre-market approval of Alpha DaRT in patients with recurrent head & neck cancer

https://www.alphatau.com/single-post/atm-submits-to-japanese-pmda-for-pre-market-approval-of-alpha-dart-for-recurrent-head-neck-cancer
👍️0
theswordman theswordman 1 년 전
CORP UPDATE

https://finance.yahoo.com/news/alpha-tau-medical-announces-third-213000260.html?.tsrc=rss
👍️0
theswordman theswordman 1 년 전
New video presentation. Updates about Hahn@SAB. New manuf facility.

👍️0
theswordman theswordman 1 년 전
Alpha Tau adds another manuf facility in U.S. So this is certainly getting ahead (cart before the horse??)
https://www.alphatau.com/single-post/atm-enters-into-long-term-lease-of-site-in-new-hampshire-for-second-u-s-manufacturing-facility

The Hudson site promises to be larger than our existing Lawrence site, and is expected to support our goals of materially scaling up capacity as well as achieving manufacturing redundancy
👍️0
theswordman theswordman 1 년 전
Hahn joins Science Advisor Board

https://www.marketscreener.com/quote/stock/ALPHA-TAU-MEDICAL-LTD-134583875/news/Alpha-Tau-Medical-Ltd-Announces-Stephen-M-Hahn-Joins-Scientific-Advisory-Board-45136482/
👍️0
theswordman theswordman 1 년 전
Latest DRTS presentation
👍️0
theswordman theswordman 1 년 전
2nd patient treated for inoperable pancreatic cancer. 1St was in Montreal

https://www.globenewswire.com/news-release/2023/09/14/2743253/0/en/Alpha-Tau-Treats-First-Patient-with-Advanced-Inoperable-Pancreatic-Cancer-at-Israel-s-Hadassah-Medical-Center.html
👍️0
Awl416 Awl416 1 년 전
Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT
👍️0
theswordman theswordman 2 년 전
New K O L event

👍️0
theswordman theswordman 2 년 전
CORP UPDATE

https://www.alphatau.com/single-post/alpha-tau-medical-announces-first-quarter-2023-financial-results-and-provides-corporate-update
👍️0
theswordman theswordman 2 년 전
With our Breakthrough Device Designation for the treatment of certain patients with squamous cell carcinoma, we look forward to swift accrual into our U.S. pivotal ReSTART trial, with the goal of bringing the Alpha DaRT closer to availability for patients as quickly as possible."

The results of the trial demonstrated that the treatment was successfully delivered to ten of ten patients, with a 100% CR observed at 12 and 24 weeks,

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804784
👍️0
theswordman theswordman 2 년 전
New buy rating

https://beststocks.com/alpha-tau-medical-receives-buy-rating-and-hig/
👍️0

최근 히스토리

NASDAQ
DRTS
Alpha Tau Medical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유